Digital Intervention for Symptom Management in Cancer and Opioid Sparing Using Virtual Reality (DISCOVR) Study
Recruiting now · Not applicable
Conditions studied: Cancer
In brief
Patients living with cancer commonly have chronic pain due to the disease or to cancer treatments. Virtual reality, a new technology that immerses the user in pleasant, diverting, and exciting virtual environments, may lower chronic cancer pain to improve quality of life and complement need for pain medications like opioids. The investigators aim to learn from patients about the experience of cancer pain, develop a virtual reality prototype specific to cancer pain management, and test the feasibility and acceptability of this technology to improve the cancer pain experience.
Key facts
- Study ID
- NCT07228377
- Run by
- Medstar Health Research Institute
- People needed
- 25
- Starts
- 2025-12-01
- Expected to finish
- 2026-08-31
- Last updated by the study team
- 2025-12-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- age ≥18 years old
- living with active cancer diagnosis (any solid tumor type)
- report chronic cancer pain (≥3 months) with baseline severity moderate-severe (i.e., self-report pain score (SRPS) ≥4/10, where 0=no pain, 10=worst pain)
- prescribed chronic opioid therapies (may be long-acting formulations, short-acting formulations, or both)
You may not qualify if…
- history of intractable nausea/vomiting, motion sickness, seizures/epilepsy, and/or cranial structure abnormalities preventing VR headset use
- moderate-severe pain of non-cancer etiology (e.g., chronic lumbago)
- enrolled in another pain study
- unable to complete surveys in English or Spanish.
Where it is running
- MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center — Washington D.C., District of Columbia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.